IRVINE, Calif., March 26, 2024 /PRNewswire/ — VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer had their urine-based biomarker featured in a recent peer-reviewed…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
